A Study to Learn About the Medicine Called Nirmatrelvir/Ritonavir in Healthy Lactating Women
Status:
Not yet recruiting
Trial end date:
2023-08-10
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to measure the amount of study drug (nirmatrelvir) that is
secreted in human breast milk when it is given to healthy breastfeeding women.